[go: up one dir, main page]

ZA200707900B - Sublingual coated tablet - Google Patents

Sublingual coated tablet

Info

Publication number
ZA200707900B
ZA200707900B ZA200707900A ZA200707900A ZA200707900B ZA 200707900 B ZA200707900 B ZA 200707900B ZA 200707900 A ZA200707900 A ZA 200707900A ZA 200707900 A ZA200707900 A ZA 200707900A ZA 200707900 B ZA200707900 B ZA 200707900B
Authority
ZA
South Africa
Prior art keywords
coated tablet
sublingual coated
sublingual
tablet
fentanyl
Prior art date
Application number
ZA200707900A
Other languages
English (en)
Inventor
Oury Pascal
Benoist Guillaume
Herry Catherine
Duvochel Joseph
Original Assignee
Ethypharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm Sa filed Critical Ethypharm Sa
Publication of ZA200707900B publication Critical patent/ZA200707900B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Formation And Processing Of Food Products (AREA)
ZA200707900A 2005-03-18 2006-03-20 Sublingual coated tablet ZA200707900B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0502727A FR2883179B1 (fr) 2005-03-18 2005-03-18 Comprime enrobe

Publications (1)

Publication Number Publication Date
ZA200707900B true ZA200707900B (en) 2009-01-28

Family

ID=35309611

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200707900A ZA200707900B (en) 2005-03-18 2006-03-20 Sublingual coated tablet

Country Status (25)

Country Link
US (2) US20080226717A1 (xx)
EP (1) EP1858491B1 (xx)
JP (1) JP5138577B2 (xx)
KR (1) KR101239926B1 (xx)
CN (1) CN101141951B (xx)
AT (1) ATE507824T1 (xx)
AU (1) AU2006224690B2 (xx)
BR (1) BRPI0608505B8 (xx)
CA (1) CA2599502C (xx)
CY (1) CY1111729T1 (xx)
DE (1) DE602006021713D1 (xx)
DK (1) DK1858491T3 (xx)
ES (1) ES2365984T3 (xx)
FR (1) FR2883179B1 (xx)
IL (1) IL185626A (xx)
MX (1) MX2007011440A (xx)
NO (1) NO338771B1 (xx)
NZ (1) NZ561154A (xx)
PL (1) PL1858491T3 (xx)
PT (1) PT1858491E (xx)
RU (1) RU2403043C2 (xx)
SI (1) SI1858491T1 (xx)
UA (1) UA88509C2 (xx)
WO (1) WO2006097361A1 (xx)
ZA (1) ZA200707900B (xx)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004311879B2 (en) * 2003-12-31 2010-08-05 Phoenix Labs Unlimited Company Effervescent oral opiate dosage form
FR2883179B1 (fr) * 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
US20090082466A1 (en) * 2006-01-27 2009-03-26 Najib Babul Abuse Resistant and Extended Release Formulations and Method of Use Thereof
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8252328B2 (en) 2006-01-06 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US9289583B2 (en) 2006-01-06 2016-03-22 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8753308B2 (en) 2006-01-06 2014-06-17 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8357114B2 (en) 2006-01-06 2013-01-22 Acelrx Pharmaceuticals, Inc. Drug dispensing device with flexible push rod
US9066847B2 (en) 2007-01-05 2015-06-30 Aceirx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
US8535714B2 (en) 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
CN101394863B (zh) * 2006-01-06 2016-12-21 阿塞尔Rx制药有限公司 小体积口腔经粘膜剂型
US8865743B2 (en) * 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8202535B2 (en) 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US8252329B2 (en) 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US20070286900A1 (en) * 2006-06-09 2007-12-13 Catherine Herry Low dose tablets of opioid analgesics and preparation process
US20100233257A1 (en) * 2006-06-09 2010-09-16 Ethypharm Low dose sublingual tablets of opioid analgesics and preparation process
DE102006054638B4 (de) * 2006-11-16 2014-12-04 Laburnum Gmbh Pharmazeutische Einzeldosisform
CA2673837C (en) * 2007-01-05 2015-11-24 Acelrx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
AU2008216867B2 (en) * 2007-02-09 2014-01-30 Durect Corporation Transoral dosage forms comprising sufentanil and naloxone
KR101606944B1 (ko) * 2007-08-07 2016-03-28 아셀알엑스 파마슈티컬스 인코퍼레이티드 경구 경점막 투여형을 사용한 시술시 진정과 무통을 위한 조성물 및 방법
FR2920308B1 (fr) * 2007-09-05 2011-02-25 Unither Dev Forme pharmaceutique pour l'administration par voie orale de principes actifs.
CA2709905A1 (en) * 2007-12-17 2009-06-25 Alfred Liang Abuse-resistant oxycodone composition
US20090263476A1 (en) * 2008-04-16 2009-10-22 Jobdevairakkam Christopher N Composition of Rapid Disintegrating Direct Compression Buccal Tablet
US8945592B2 (en) * 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
WO2010144865A2 (en) 2009-06-12 2010-12-16 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
ES2699077T3 (es) * 2009-06-12 2019-02-07 Sunovion Pharmaceuticals Inc Apomorfina sublingual
US20110091544A1 (en) * 2009-10-16 2011-04-21 Acelrx Pharmaceuticals, Inc. Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting
US20110288128A1 (en) * 2010-05-21 2011-11-24 Acelrx Pharmaceuticals, Inc. Oral Transmucosal Administration of Sufentanil
EP2455069A1 (de) * 2010-11-11 2012-05-23 Laburnum GMBH Wirkstofffreie Darreichungsform, Verfahren zu deren Herstellung sowie deren Verwendung
PH12013501345A1 (en) * 2010-12-23 2022-10-24 Purdue Pharma Lp Tamper resistant solid oral dosage forms
CN103648487B (zh) * 2011-05-13 2019-04-19 Eb Ip希博里塔布斯有限责任公司 药物递送系统
PT2706986E (pt) 2011-09-19 2015-07-07 Orexo Ab Nova composição farmacêutica resistente ao abuso para o tratamento da dependência de opiáceos
RS57951B1 (sr) 2012-05-02 2019-01-31 Orexo Ab Nova kompozicija alfentanila za tretman akutnog bola
CN102755322B (zh) * 2012-07-24 2013-12-11 兆科药业（广州）有限公司 一种乐卡地平和阿托伐他汀复方制剂
CA2919892C (en) 2013-08-12 2019-06-18 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
EP2886103A1 (en) * 2013-12-23 2015-06-24 Hexal AG Pharmaceutical orodispersible film comprising buprenorphine particles with a particular size
DK3169315T3 (da) 2014-07-17 2020-08-10 Pharmaceutical Manufacturing Res Services In Væskefyldt doseringsform til forhindring af misbrug med øjeblikkelig frigivelse
EP3209282A4 (en) 2014-10-20 2018-05-23 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
EP3578164A1 (en) * 2018-06-05 2019-12-11 Bio-Gate AG Thixotropic composition
CA3116730A1 (en) * 2018-10-19 2020-04-23 Nova Southeastern University Sublingual epinephrine compositions including ph-modifying excipients and penetration enhancers and methods for use thereof
CN209673136U (zh) 2019-05-07 2019-11-22 深圳市华普森电子有限公司 高清智能一体化管道探测器
JP2022141158A (ja) * 2021-03-15 2022-09-29 株式会社パウレック コーティング錠
WO2025170507A1 (en) * 2024-02-07 2025-08-14 Oncozenge Ab A lozenge

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL282752A (xx) * 1961-09-10
US5288498A (en) * 1985-05-01 1994-02-22 University Of Utah Research Foundation Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
US4671953A (en) * 1985-05-01 1987-06-09 University Of Utah Research Foundation Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics
US4673679A (en) * 1986-05-14 1987-06-16 E. I. Du Pont De Nemours And Company Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration
JPS6327424A (ja) 1986-07-17 1988-02-05 Shionogi & Co Ltd 徐放性製剤およびその製造法
FR2621483B1 (fr) 1987-10-08 1991-09-20 Medibrevex Nouvelles formes galeniques de corticoides pour administration par voie per- et sublinguale et leur procede de preparation
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
US5286493A (en) 1992-01-27 1994-02-15 Euroceltique, S.A. Stabilized controlled release formulations having acrylic polymer coating
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
WO1994009762A1 (en) * 1992-11-05 1994-05-11 Merck & Co., Inc. Drug delivery device
US5411745A (en) * 1994-05-25 1995-05-02 Euro-Celtique, S.A. Powder-layered morphine sulfate formulations
US5744164A (en) 1994-12-16 1998-04-28 Nestec S.A. Sustained release microparticulate caffeine formulation
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
FR2771291B1 (fr) 1997-11-21 2000-02-25 Ethypharm Lab Prod Ethiques Spheroides, procede de preparation et compositions pharmaceutiques
FR2769524B1 (fr) 1998-01-06 1999-12-31 Ethypharm Lab Prod Ethiques Dispositif d'enrobage pour granules a absorber par voie orale
FR2774910B1 (fr) * 1998-02-16 2001-09-07 Ethypharm Lab Prod Ethiques Microgranules de sulfate de morphine, procede de fabrication et preparations pharmaceutiques
US6200604B1 (en) * 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
ES2157731B1 (es) 1998-07-21 2002-05-01 Liconsa Liberacion Controlada Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
SE9803240D0 (sv) 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
SE9803239D0 (sv) 1998-09-24 1998-09-24 Diabact Ab Composition for the treatment of acute pain
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20010016593A1 (en) * 1999-04-14 2001-08-23 Wilhelmsen Paul C. Element giving rapid release of nicotine for transmucosal administration
US6248760B1 (en) * 1999-04-14 2001-06-19 Paul C Wilhelmsen Tablet giving rapid release of nicotine for transmucosal administration
FR2794646B1 (fr) 1999-06-09 2001-09-21 Ethypharm Lab Prod Ethiques Microgranules de sulfate de morphine, procede de preparation et composition les contenant
FR2796840B1 (fr) 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
US6602518B2 (en) * 2001-06-28 2003-08-05 Wm. Wrigley Jr. Company Chewable product including active ingredient
KR20040060917A (ko) 2001-08-06 2004-07-06 유로-셀티크 소시에떼 아노뉨 오피오이드 남용을 방지하기 위한 조성물 및 방법
US20030191147A1 (en) * 2002-04-09 2003-10-09 Barry Sherman Opioid antagonist compositions and dosage forms
KR20050096950A (ko) * 2003-01-31 2005-10-06 오렉쏘 에이비 신속-작용 약학 조성물
FR2855756B1 (fr) 2003-06-06 2005-08-26 Ethypharm Sa Comprime orodispersible multicouche
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe

Also Published As

Publication number Publication date
EP1858491A1 (en) 2007-11-28
JP5138577B2 (ja) 2013-02-06
NZ561154A (en) 2010-12-24
KR101239926B1 (ko) 2013-03-07
PL1858491T3 (pl) 2012-03-30
FR2883179B1 (fr) 2009-04-17
DE602006021713D1 (de) 2011-06-16
BRPI0608505B8 (pt) 2021-05-25
CY1111729T1 (el) 2015-10-07
WO2006097361A1 (en) 2006-09-21
AU2006224690B2 (en) 2011-09-29
HK1109730A1 (en) 2008-06-20
US8709479B2 (en) 2014-04-29
CN101141951A (zh) 2008-03-12
IL185626A0 (en) 2008-01-06
ATE507824T1 (de) 2011-05-15
IL185626A (en) 2014-09-30
RU2007138647A (ru) 2009-04-27
CA2599502A1 (en) 2006-09-21
ES2365984T3 (es) 2011-10-14
CA2599502C (en) 2013-05-14
BRPI0608505B1 (pt) 2021-05-04
BRPI0608505A2 (pt) 2010-01-05
FR2883179A1 (fr) 2006-09-22
NO338771B1 (no) 2016-10-17
UA88509C2 (ru) 2009-10-26
NO20075345L (no) 2007-12-17
US20060210632A1 (en) 2006-09-21
KR20070114756A (ko) 2007-12-04
AU2006224690A1 (en) 2006-09-21
CN101141951B (zh) 2011-02-09
MX2007011440A (es) 2007-11-14
US20080226717A1 (en) 2008-09-18
DK1858491T3 (da) 2011-08-22
EP1858491B1 (en) 2011-05-04
RU2403043C2 (ru) 2010-11-10
JP2008533084A (ja) 2008-08-21
SI1858491T1 (sl) 2011-09-30
PT1858491E (pt) 2011-08-18

Similar Documents

Publication Publication Date Title
IL185626A0 (en) Sublingual coated tablet
SG171584A1 (en) Nanoparticulate metal boride composition and its use for identification- marking plastic parts
MX2008001799A (es) Composicion farmaceutica que comprende un inhibidor de dipeptidil peptidasa iv.
PT1976521E (pt) Aerossol sublingual de fentanilo
IL181303A0 (en) Method for the production of dihydropteridinones
IL181588A0 (en) PRODUCTION OF-TNFR-Ig
TW200617019A (en) A process for the preparation of 7α-alkylated 19-norsteroids
IL198845A0 (en) Sustained-release composition and method for producing the same
GB0424323D0 (en) Tablet
GB0525021D0 (en) Coating thickness gauge
EP1843232A4 (en) PRODUCTION PROGRAMMING SYSTEM
EP2095928A4 (en) DISC THICKNESS, DISC SUBSTRATE AND METHOD OF FORMING THE DISC SUBSTRATE
DE602006008339D1 (en) Zolpidemtabletten
AU304349S (en) Stamp
EP1829458A4 (en) SYSTEM FOR MANUFACTURING CIGARETTES
PL1920914T3 (pl) Płyta dekoracyjna i sposób jej wytwarzania
PT1867324T (pt) Comprimido¿
IL184372A0 (en) Method for delivering interferon-??
GB0506349D0 (en) Forming method
HU0500004V0 (en) Punch for gum
GB0525191D0 (en) Coating thickness gauge
GB0411878D0 (en) Gas production
ZA200903644B (en) Sustained-release composition and method for producing the same
AU2004902004A0 (en) Religious jewellery
GB0524839D0 (en) Gas distributor